Special Opportunities London listing falls flat after REIT fails to meet fundraising target June 12, 2024 Special Opportunities REIT has pulled its IPO, scuppering the first stock market listing of a UK real estate investment trust in three years.
Exclusive: Why this London-based AI firm has picked Aquis for its float next month June 12, 2024 Pri0r1ty AI automates tasks like writing press releases, regulatory news, and social media content, typically handled by multiple external agencies.
London listings to rebound from second half of 2024, broker predicts June 10, 2024 The UK's IPO market is starting to open up, according to a leading broker, as it eyes a rebound in listings from the second half of this year.
London might be behind on IPOs… But there is one bright spot June 3, 2024 We all know the London Stock Exchange is doing badly on IPOs, but follow-ons represent a bright spot in the market.
Boots: Profit surges at British icon as owner mulls £7bn London float May 29, 2024 Historic pharmacy chain Boots has reported a surge in its pre-tax profit for its latest financial year amid reports its owner is considering a £7bn float in London.
Bioscope: Cambridge biotech gold extractor firm eyes IPO May 29, 2024 Bioscope Technologies, which uses micro-organisms to draw out gold and precious metals, currently has a £12.8m turnover.
Arm to act as cornerstone investor for Raspberry Pi as it confirms intention to float May 22, 2024 London can breathe a sigh of relief as Raspberry Pi has confirmed its intention to IPO on the LSE, following months of teasing the move.
UK venture capital investment slumps to lowest levels since Brexit vote despite DAZN and Castore deals March 25, 2024 The amount of venture capitalist investment in the UK slumped by 45 per cent in 2023, according to new data.
Reddit targets £5bn valuation in US public float with users able to buy stock March 11, 2024 If successful, the IPO could see Reddit raising more than $500m, with a potential to reach up to $748m if it sells about 22m shares.
Redx Pharma denies US listing plan following report February 14, 2024 Redx Pharma has denied it is currently in the process of listing in the US following a report in The Times.